Novavax Phase III and Phase II B Trial Results | drbeen
Author declares no conflict of interest.
Get free trial
with access to all our lectures
DrBeen Logo

no credit card required

My Notes

Become a member to create study notes.
Sign up for free trial
Novavax Phase III and Phase II B Trial Results Duration: 978
Microbiology / Virology

Learning Objectives

Novavax is a partial protein based or subprotein based vaccine. We will discuss following topics in this session:

1. Why is Novavax vaccine different from other vaccines?

2. How is the Novavax partial-protein vaccine manufactured?

3. What adjuvant is used in building this vaccine?

4. Trial results from the UK phase III trial, and South Africa phase II trials of Novavax.

5. Will the vaccine help against the South African variant?


Dr. Mobeen Syed

Dr. Mobeen Syed

Mobeen Syed M.D, MS Graduated from King Edward Medical University. Entrepreneur, Medical Educator, CEO and founder of Drbeen corp.

Videos in this series